Last updated: July 10, 2026

Application No. 19/412,760

Untitled Application

Unknown

Filed

Priority

Nov 08, 2024 — provisional 63/717,948 +1 more

Examiner

JAVANMARD, SAHAR

Art Unit

Tech Center

Xenon Pharmaceuticals Inc.

Assignee

Xenon Pharmaceuticals Inc.

OA Round

1 (Non-Final)

Interview Optional

— +34.8% interview lift. Examiner has a relatively high allowance rate (65%); +34.8% interview lift. A written response may suffice.

Based on 741 resolved cases, 2023–2026

Examiner Intelligence

JAVANMARD, SAHAR View full profile →

Grants 65% — above average

Career Allowance Rate

483 granted / 741 resolved

+5.2% vs TC avg

Strong +35% interview lift

Without

With

+34.8%

Interview Lift

resolved cases with interview

Typical timeline

2y 10m

Avg Prosecution

49 currently pending

Career history

782

Total Applications

across all art units

Statute-Specific Performance

§101

0.1%

-39.9% vs TC avg

§103

75.5%

+35.5% vs TC avg

§102

8.8%

-31.2% vs TC avg

§112

8.4%

-31.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 741 resolved cases

Prosecution Timeline

May 13, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/264,809

Patent 12673956

OXADIAZOLYL DIHYDROPYRANO[2,3-b]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS

2y 11m to grant Granted Jul 07, 2026

18/009,107

Patent 12667563

PROPHYLACTIC OR THERAPEUTIC AGENT FOR PORPHYRIA

3y 6m to grant Granted Jun 30, 2026

19/299,240

Patent 12661352

COMBINATION THERAPY WITH CLK/DYRK INHIBITORS AND BCL2 INHIBITORS TO TREAT LEUKEMIA

10m to grant Granted Jun 23, 2026

17/639,365

Patent 12653819

FORMULATIONS AND TREATMENT METHODS

4y 3m to grant Granted Jun 16, 2026

18/320,001

Patent 12653855

OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES

3y 1m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

65%

Grant Probability

99%

With Interview (+34.8%)

2y 10m

Median Time to Grant

Low

PTA Risk

Based on 741 resolved cases by this examiner. Grant probability derived from career allowance rate.